Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
111,111,111
-
Number of holders
-
255
-
Total 13F shares, excl. options
-
70,226,112
-
Shares change
-
+1,091,036
-
Total reported value, excl. options
-
$4,727,523,890
-
Value change
-
+$67,830,767
-
Put/Call ratio
-
1.49%
-
Number of buys
-
140
-
Number of sells
-
-118
-
Price
-
$67.34
Significant Holders of NovoCure Ltd - Common Stock (NVCR) as of Q1 2020
328 filings reported holding NVCR - NovoCure Ltd - Common Stock as of Q1 2020.
NovoCure Ltd - Common Stock (NVCR) has 255 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70,226,112 shares
of 111,111,111 outstanding shares and own 63.2% of the company stock.
Largest 10 shareholders include FMR LLC (11,839,159 shares), BAILLIE GIFFORD & CO (7,736,618 shares), VANGUARD GROUP INC (7,418,256 shares), BlackRock Inc. (5,670,686 shares), Capital World Investors (4,935,348 shares), Capital International Investors (2,555,725 shares), RENAISSANCE TECHNOLOGIES LLC (2,245,470 shares), STATE STREET CORP (1,742,591 shares), Darsana Capital Partners LP (1,350,000 shares), and MACQUARIE GROUP LTD (1,306,445 shares).
This table shows the top 255 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.